S. 1097Introduced
Interagency Patent Coordination and Improvement Act of 2025
Establishes an interagency patent task force to coordinate USPTO and FDA work on patents for human drugs and biological products
Plain-English overview
What this bill does
Establishes an interagency patent task force to coordinate USPTO and FDA work on patents for human drugs and biological products
Key points
- Establish interagency patent task force
- Require USPTO FDA information sharing
- Direct USPTO assistance with patent listing
Current status
Where it stands
Status
Introduced
Latest action
2025-04-10 — Placed on Senate Legislative Calendar under General Orders. Calendar No. 41.
Related context
Topics and policy areas
undefinedAdministrative remediesCommerceDepartment of CommerceDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)Intellectual propertyIntergovernmental relations